What are LB Pharmaceuticals Inc Common Stock's total assets?

LB Pharmaceuticals Inc Common Stock (LBRX) holds $393.5M in total assets.

How much debt does LB Pharmaceuticals Inc Common Stock have?

LB Pharmaceuticals Inc Common Stock carries $3.5M in total debt against $378.7M of shareholders' equity, a debt-to-equity ratio of 0.01.

How much cash does LB Pharmaceuticals Inc Common Stock have?

LB Pharmaceuticals Inc Common Stock holds $320.7M in cash and equivalents.

Can LB Pharmaceuticals Inc Common Stock cover its short-term obligations?

Its current ratio is 35.68 — current assets exceed current liabilities.

Where does LB Pharmaceuticals Inc Common Stock's balance sheet data come from?

Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LB Pharmaceuticals Inc Common Stock LBRX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$320.68M—	$250.17M+989%	$269.74M—	——	——
Short-term investments	$44.96M—	$45.04M+797%	$44.74M—	——	——
Restricted cash	$776K—	$770K+54.6%	$512K—	——	——
Prepaid expenses and other current assets	$23.44M+28,339%	$13.22M+1,402%	$1.92M+338%	——	-$83K-119%
Total current assets	$389.07M—	$308.43M+968%	$316.4M—	——	——
Property and equipment, net	$1.53M—	$1.58M-15.0%	$1.64M—	——	——
Operating lease right-of-use assets	$2.1M—	$2.15M-6.4%	$2.2M—	——	——
Total assets	$393.48M—	$312.93M+833%	$320.75M—	——	——
Accounts payable	$7.12M—	$2.13M-8.3%	$2.59M—	——	——
Accrued expenses	$3.06M—	$4.59M-13.5%	$3.33M—	——	——
Operating lease liabilities, current	$730K—	$730K+49.9%	$730K—	——	——
Total current liabilities	$10.91M—	$7.44M-8.2%	$6.65M—	——	——
Operating lease liabilities, non-current	$2.74M—	$2.84M-11.7%	$2.94M—	——	——
Operating Lease Liabilities (Total)	$3.47M—	$3.57M-3.6%	$3.67M—	——	——
Total liabilities	$14.79M—	$11.62M-15.9%	$10.53M—	——	——
Common stock	$3K—	$3K+200%	$114.3M—	——	——
Additional paid-in capital	$527.06M—	$430.67M+4,360%	$428.33M—	——	——
Retained earnings	-$148.58M—	-$129.53M-24.2%	-$118.06M—	——	——
Accumulated other comprehensive income (loss)	$208K—	$168K+51.4%	-$53K—	——	——
Total stockholders' equity	$378.69M+481%	$301.31M+419%	$310.22M+439%	-$103.87M-34.1%	-$99.34M-96.9%
Total liabilities and stockholders' equity	$393.48M—	$312.93M+833%	$320.75M—	——	——
Short- term Investments	$44.96M—	$45.04M+797%	$44.74M—	——	——
Net Investment in Lease	$2.1M—	$2.15M-6.4%	$2.2M—	——	——
Operating lease right-of-use assets	$2.1M—	$2.15M-6.4%	$2.2M—	——	——
Operating Lease Right-of-Use Assets in Other Assets	$2.1M—	$2.15M-6.4%	$2.2M—	——	——
Other Commercial Liabilities	$3.06M—	$4.59M-13.5%	$3.33M—	——	——
Accrued Liabilities, Current	$3.06M—	$4.59M-13.5%	$3.33M—	——	——
Derivative Liabilities - Fair Value	$1.14M—	$1.34M-46.4%	$942K—	——	——
Derivative Liabilities (Non-Current)	$1.14M—	$1.34M-46.4%	$942K—	——	——
Total debt	$3.47M—	$3.57M-3.6%	$3.67M—	——	——
Additional paid-in capital	$527.06M—	$430.67M+4,360%	$428.33M—	——	——
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$3K—	$3K+200%	$114.3M—	——	——
Derivative Liability, Noncurrent	$1.14M—	$1.34M-46.4%	$942K—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are LB Pharmaceuticals Inc Common Stock's total assets?: LB Pharmaceuticals Inc Common Stock (LBRX) holds $393.5M in total assets.
How much debt does LB Pharmaceuticals Inc Common Stock have?: LB Pharmaceuticals Inc Common Stock carries $3.5M in total debt against $378.7M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does LB Pharmaceuticals Inc Common Stock have?: LB Pharmaceuticals Inc Common Stock holds $320.7M in cash and equivalents.
Can LB Pharmaceuticals Inc Common Stock cover its short-term obligations?: Its current ratio is 35.68 — current assets exceed current liabilities.
Where does LB Pharmaceuticals Inc Common Stock's balance sheet data come from?: Every line is extracted from LB Pharmaceuticals Inc Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.